These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19765774)

  • 1. A metabolic cause of spinal deformity.
    Effelsberg NM; Hügle T; Walker UA
    Metabolism; 2010 Jan; 59(1):140-3. PubMed ID: 19765774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaptonuria presenting with ochronotic spondyloarthropathy.
    Al-Mahfoudh R; Clark S; Buxton N
    Br J Neurosurg; 2008 Dec; 22(6):805-7. PubMed ID: 19085367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nitisinone in patients with alkaptonuria.
    Suwannarat P; O'Brien K; Perry MB; Sebring N; Bernardini I; Kaiser-Kupfer MI; Rubin BI; Tsilou E; Gerber LH; Gahl WA
    Metabolism; 2005 Jun; 54(6):719-28. PubMed ID: 15931605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of alkaptonuria.
    Phornphutkul C; Introne WJ; Perry MB; Bernardini I; Murphey MD; Fitzpatrick DL; Anderson PD; Huizing M; Anikster Y; Gerber LH; Gahl WA
    N Engl J Med; 2002 Dec; 347(26):2111-21. PubMed ID: 12501223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R
    Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.
    Introne WJ; Phornphutkul C; Bernardini I; McLaughlin K; Fitzpatrick D; Gahl WA
    Mol Genet Metab; 2002; 77(1-2):136-42. PubMed ID: 12359141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ashy ears.
    Rallis E; Kintzoglou S
    ScientificWorldJournal; 2010 Aug; 10():1530-1. PubMed ID: 20694448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkaptonuria.
    Yancovitz M; Anolik R; Pomeranz MK
    Dermatol Online J; 2010 Nov; 16(11):6. PubMed ID: 21163157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine homogentisic acid and tyrosine: simultaneous analysis by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Christensen P; Ross G; Davison AS; Gallagher JA; Dutton JJ; Ranganath LR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():106-12. PubMed ID: 24952314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
    Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
    J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic low backache and stiffness may not be due ankylosing spondylitis.
    Ahmed S; Shah Z; Ali N
    J Pak Med Assoc; 2010 Aug; 60(8):681-3. PubMed ID: 20726204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical images: Magnetic resonance imaging appearance of alkaptonuria.
    Hamdulay SS; Finegold J; Boyer L; Khanna M; Akmal M; Walker A; Kinderlerer A
    Arthritis Rheum; 2012 Jan; 64(1):129. PubMed ID: 21953018
    [No Abstract]   [Full Text] [Related]  

  • 13. Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.
    Hughes JH; Liu K; Plagge A; Wilson PJM; Sutherland H; Norman BP; Hughes AT; Keenan CM; Milan AM; Sakai T; Ranganath LR; Gallagher JA; Bou-Gharios G
    Hum Mol Genet; 2019 Dec; 28(23):3928-3939. PubMed ID: 31600782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R58fs mutation in the HGD gene in a family with alkaptonuria in the UAE.
    Abdulrazzaq YM; Ibrahim A; Al-Khayat AI; Nagelkerke N; Ali BR
    Ann Hum Genet; 2009 Jan; 73(1):125-30. PubMed ID: 18945288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
    Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
    Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Davison AS; Christensen P; Ross G; Gallagher JA; Dutton JJ; Ranganath LR
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):597-605. PubMed ID: 25628464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.
    Milan AM; Hughes AT; Davison AS; Devine J; Usher J; Curtis S; Khedr M; Gallagher JA; Ranganath LR
    Ann Clin Biochem; 2017 May; 54(3):323-330. PubMed ID: 28081634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthopaedic problems in patients affected by alkaptonuria. A case report.
    Kopeć K; Kusz D; Wojciechowski P; Cieliński L; Laszczyca M
    Ortop Traumatol Rehabil; 2007; 9(2):206-14. PubMed ID: 17514166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria.
    Suzuki Y; Oda K; Yoshikawa Y; Maeda Y; Suzuki T
    J Hum Genet; 1999; 44(2):79-84. PubMed ID: 10083729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A child with dark discoloration of urine].
    Jeucken YM; Visser G; Jaarsma AS; van Spronsen FJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1641-3. PubMed ID: 10494297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.